Allen, Ryan M. http://orcid.org/0000-0002-8057-3436
Michell, Danielle L. http://orcid.org/0000-0002-2048-4191
Cavnar, Ashley B.
Zhu, Wanying
Makhijani, Neil
Contreras, Danielle M.
Raby, Chase A.
Semler, Elizabeth M.
DeJulius, Carlisle
Castleberry, Mark
Zhang, Youmin
Ramirez-Solano, Marisol
Zhao, Shilin
Duvall, Craig http://orcid.org/0000-0003-3979-0620
Doran, Amanda C.
Sheng, Quanhu http://orcid.org/0000-0001-8951-9295
Linton, MacRae F.
Vickers, Kasey C. http://orcid.org/0000-0001-5643-3102
Funding for this research was provided by:
American Heart Association (19CDA34660280, 18IPA34180005)
W. M. Keck Foundation
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (P01HL116263, R01HL128996)
Article History
Received: 22 December 2020
Accepted: 18 October 2022
First Online: 6 December 2022
Competing interests
: M.F.L. has received research funding from Amgen, Regeneron, Ionis, Merck, REGENXBIO, Sanofi and Novartis, and has served as a consultant for Esperion, Alexion Pharmaceuticals and REGENXBIO. All other authors have no competing interests.
Free to read: This content has been made available to all.